Telomerase-based therapies emerging slowly.
Brower
Vicki
V
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology; D019496:Cancer Vaccines / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000201:enzymology; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000201:enzymology; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D009841:Oligonucleotides / Q000494:pharmacology; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000201:enzymology; D010446:Peptide Fragments / Q000494:pharmacology; D019098:Telomerase / Q000187:drug effects* / Q000378:metabolism / Q000494:pharmacology; D016615:Telomere / Q000201:enzymology*; D035321:Telomeric Repeat Binding Protein 1 / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D004791:Enzyme Inhibitors; C505952:GRN163L peptide; D009841:Oligonucleotides; D010446:Peptide Fragments; D035321:Telomeric Repeat Binding Protein 1; C509186:TERT protein, human; D019098:Telomerase